AzTrials
AzTrials

EngorgementNCT01619371

Engorgement Study With a Double Electric Breast Pump

An observational study of Engorgement, run by Foundation for Maternal Infant and Lactation Knowledge at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to analyze the effectiveness of an FDA approved Class II medical device, the Simplisse Double Electric Breast Pump, in relieving the symptoms of engorgement. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Engorgement
What is being tested?
Simplisse Double Electric Breast Pump
Type of treatment
Medical device
How many people
21 participants
Where
1 siteUnited States
Study dates
Mar 2011to May 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: First 20 women arriving at the Newborn Care Center clinic in Reno, Nevada during their first week postpartum seeking lactation management assistance for engorgement.

Who may be able to join

  • first week postpartum seeking lactation management assistance for engorgement, identified as clinically engorged by health care practitioner.

Who cannot join

  • greater than one week postpartum
  • less than 18 years of age
  • non-English speakers
  • not willing to use double electric breast pump

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Newborn Care Center Clinic

    Reno, Nevada, 89502

Other trials in United States

About this study

Official title: Engorgement Study With the Simplisse Double Electric Breast Pump

The purpose of this study is to analyze the effectiveness of an FDA approved Class II medical device, the Simplisse Double Electric Breast Pump, in relieving the symptoms of engorgement.

Conditions
Engorgement
Being tested
Simplisse Double Electric Breast Pump
Keywords
breast pump, engorgement, lactation
Medical subject headings
Hyperemia, Breast Milk Expression, Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Simplisse Double Electric Breast PumpDevice

    Also called Simplisse Double Electric Breast Pump, 1005S

    Use of breast pump for 10 minutes.

Study groups in NCT01619371
Study groupRoleWhat they receive
Lactating womenLactating women willing to use a breast pump.
Receives: Device: Simplisse Double Electric Breast Pump

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Engorgement Relief

    Relief of engorgement as measured by the engorgement scale.

    Measured: 10 minutes per subject

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jun 2012 (estimated)
  2. Study startMar 2011
  3. Primary completionMay 2011
  4. Study completionMay 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
21 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01619371
Sponsor's protocol ID
2614
Status last verified
Jun 2012
First submitted
12 Jun 2012
Last updated
14 Jun 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

An observational study of Engorgement, run by Foundation for Maternal Infant and Lactation Knowledge at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jun 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Engorgement Relief (time frame: 10 minutes per subject). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jun 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in